IFN-γ polyclonal, anti-human
€0.00
In stock
SKU
AC-ABG10163
Catalog Number: AC-ABG10163
Size(s): 50 µg, 100 µg
Host: Rabbit
Applications: WB, IHC, E
Datasheet
Request Information
Size(s): 50 µg, 100 µg
Host: Rabbit
Applications: WB, IHC, E
Datasheet
Request Information
Source:
Produced from sera of rabbits pre-immunized with highly pure recombinant Human IFN-gamma. Anti-Human IFN-gamma specific antibody was purified by affinity chromatography employing immobilized Human IFN-gamma matrix.
Western Blot:
To detect Human IFN-gamma by Western Blot analysis this antibody can be used at a concentration of 0.1- 0.2 μg/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Human IFN-gamma is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.
Sandwich ELISA:
To detect Human IFN-gamma by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with BioGems Biotinylated Anti-Human IFN-gamma (60-182BT) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human IFN-gamma.
Immunohistochemistry:
This antibody stained formalin-fixed, paraffin-embedded sections of human cervical squamous cell carcinoma. The recommended concentration is 0.5 μg/ml-0.25μg/ml with an overnight incubation at 4°C. An HRP-labeled polymer detection system was used with a DAB chromogen. Heat induced antigen retrieval with a pH 6.0 sodium citrate buffer is recommended. Optimal concentrations and conditions may vary.
Neutralization:
To yield one-half maximal inhibition [ND50] of the biological activity of Human IFN-gamma (10 ng/ml), a concentration of 0.13-0.20 μg/ml of this antibody is required.
Formulation: A sterile filtered antibody solution was lyophilized from PBS, pH 7.2.
Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml.
Produced from sera of rabbits pre-immunized with highly pure recombinant Human IFN-gamma. Anti-Human IFN-gamma specific antibody was purified by affinity chromatography employing immobilized Human IFN-gamma matrix.
Western Blot:
To detect Human IFN-gamma by Western Blot analysis this antibody can be used at a concentration of 0.1- 0.2 μg/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Human IFN-gamma is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.
Sandwich ELISA:
To detect Human IFN-gamma by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with BioGems Biotinylated Anti-Human IFN-gamma (60-182BT) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human IFN-gamma.
Immunohistochemistry:
This antibody stained formalin-fixed, paraffin-embedded sections of human cervical squamous cell carcinoma. The recommended concentration is 0.5 μg/ml-0.25μg/ml with an overnight incubation at 4°C. An HRP-labeled polymer detection system was used with a DAB chromogen. Heat induced antigen retrieval with a pH 6.0 sodium citrate buffer is recommended. Optimal concentrations and conditions may vary.
Neutralization:
To yield one-half maximal inhibition [ND50] of the biological activity of Human IFN-gamma (10 ng/ml), a concentration of 0.13-0.20 μg/ml of this antibody is required.
Formulation: A sterile filtered antibody solution was lyophilized from PBS, pH 7.2.
Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml.
| Is Featured? | No |
|---|
Write Your Own Review